Recombinant SARS-CoV-2 Spike S1 (N501Y, K417YN, E484K) on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant SARS-CoV-2 Spike S1 (N501Y, K417YN, E484K) on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant SARS-COV-2 Spike S1 (N501Y, K417N, E484K) Protein
BS-46017P
ApplicationsWestern Blot, ELISA, Other Application
Product group Proteins / Signaling Molecules
Overview
- SupplierBioss Antibodies
- Product NameRecombinant SARS-COV-2 Spike S1 (N501Y, K417N, E484K) Protein
- Delivery Days Customer16
- ApplicationsWestern Blot, ELISA, Other Application
- CertificationResearch Use Only
- ConjugateUnconjugated
- Estimated Purity>95%
- Scientific DescriptionSARS-CoV-2 exploits angiotensin-converting enzyme 2 (ACE2) as a receptor to invade cells. It has been reported that the UK and South African strains may have higher transmission capabilities, eventually in part due to amino acid substitutions on the SARS-CoV-2 Spike protein. The results of a study show the N501Y replacement in this region of the interface (present in both the UK and South African strains) should be favorable for the interaction with ACE2, while the K417N and E484K substitutions (South African strain) would seem neutral or even unfavorable.
- Storage Instruction-80°C
- UNSPSC12352202